Raskas Daniel
SEC CIK 1306860 · EDGAR
BoughtSold
Most active insiders at NVST, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Reis Mischa | SVP, Strategy, Bus. Dev | — | $510.2K |
| 2 | Acurio Veronica | Pres, Orthodontics | — | — |
| 3 | Nilsson Stefan | Pres, Nobel Biocare | — | — |
| 4 | Befidi Robert | Pres, Diagnostics | — | — |
| 5 | Kaabi Faez C | CAO | — | — |
| 6 | Pierce James Andrew | Dir | — | — |
| 7 | Nance Mark E | GC | — | — |
| 8 | Keel Paul A | CEO, Dir | — | — |
| 9 | Hammes Eric D. | CFO | — | — |
| 10 | Carruthers Wendy | Dir | — | — |
| 14 | Raskas Daniel | Dir | — | — |
Transactions 31
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-21 16:36 | 2026-05-19 | NVST | Envista Holdings Corp | Raskas Daniel | Dir | A - Grant | $0.00 | +9,330 | 54.0K | +21% | $0 | |
| 2025-06-12 | 2025-06-10 | NVST | Envista Holdings Corp | Raskas Daniel | Dir | A - Grant | $0.00 | +10.4K | 44.7K | +31% | $0 | |
| D | 2025-02-04 | 2025-02-03 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | F - Tax | $214.26 | -4,701 | 10.5K | -31% | -$1.01M |
| DM | 2024-11-27 | 2024-11-25+ | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | S - Sale+OE | $236.93 | -34.7K | 15.2K | -69% | -$8.22M |
| D | 2024-11-27 | 2024-11-26 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | M - OptEx | $58.59 | +26.3K | 41.5K | +173% | +$1.54M |
| 2024-07-26 | 2024-07-25 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | S - Sale | $270.51 | -14.5K | 23.6K | -38% | -$3.92M | |
| 2024-05-23 | 2024-05-21 | NVST | Envista Holdings Corp | Raskas Daniel | Dir | A - Grant | $0.00 | +10.1K | 34.2K | +42% | $0 | |
| D | 2024-02-27 | 2024-02-26 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | S - Sale+OE | $252.00 | -23.8K | 38.1K | -38% | -$5.99M |
| D | 2024-02-27 | 2024-02-26 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | M - OptEx | $58.48 | +23.8K | 61.9K | +62% | +$1.39M |
| D | 2024-02-27 | 2024-02-26 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | G - Gift | $0.00 | -591 | 38.1K | -2% | $0 |
| 2024-02-23 | 2024-02-21 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | A - Grant | $0.00 | +3,471 | 38.7K | +10% | $0 | |
| D | 2024-02-02 | 2024-02-01 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | F - Tax | $245.13 | -5,984 | 35.2K | -15% | -$1.47M |
| D | 2023-08-01 | 2023-07-28 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | S - Sale+OE | $260.65 | -11.2K | 38.3K | -23% | -$2.92M |
| D | 2023-08-01 | 2023-07-28 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | G - Gift | $0.00 | -385 | 38.3K | -1.0% | $0 |
| D | 2023-08-01 | 2023-07-28 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | M - OptEx | $56.70 | +11.2K | 49.5K | +29% | +$635.8K |
| D | 2023-06-01 | 2023-05-31 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | S - Sale+OE | $228.50 | -19.8K | 38.7K | -34% | -$4.54M |
| D | 2023-06-01 | 2023-05-31 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | M - OptEx | $57.90 | +19.8K | 58.5K | +51% | +$1.15M |
| 2023-05-25 | 2023-05-23 | NVST | Envista Holdings Corp | Raskas Daniel | Dir | A - Grant | $0.00 | +5,425 | 24.1K | +29% | $0 | |
| D | 2023-02-28 | 2023-02-24 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | F - Tax | $249.12 | -510 | 38.7K | -1% | -$127.1K |
| 2023-02-23 | 2023-02-22 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | A - Grant | $0.00 | +10.4K | 39.2K | +36% | $0 | |
| D | 2023-02-02 | 2023-02-01 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | F - Tax | $267.50 | -2,486 | 28.7K | -8% | -$665.0K |
| 2022-12-19 | 2022-11-04 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | G - Gift | $0.00 | -412 | 31.2K | -1% | $0 | |
| 2022-05-31 | 2022-05-24 | NVST | Envista Holdings Corp | Raskas Daniel | Dir | A - Grant | $0.00 | +4,435 | 18.7K | +31% | $0 | |
| 2022-02-25 | 2022-02-24 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | F - Tax | $271.56 | -994 | 31.6K | -3% | -$269.9K | |
| 2022-02-25 | 2022-02-23 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | A - Grant | $0.00 | +12.8K | 32.6K | +64% | $0 | |
| D | 2022-02-02 | 2022-02-01 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | F - Tax | $287.29 | -2,359 | 19.9K | -11% | -$677.7K |
| D | 2021-12-01 | 2021-11-30 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | M - OptEx | $46.13 | +12.3K | 34.5K | +55% | +$567.1K |
| D | 2021-12-01 | 2021-11-30 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | S - Sale+OE | $326.00 | -12.3K | 22.2K | -36% | -$4.01M |
| D | 2021-11-30 | 2021-11-26 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | S - Sale+OE | $325.33 | -12.3K | 22.6K | -35% | -$4.00M |
| D | 2021-11-30 | 2021-11-26 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | M - OptEx | $46.13 | +12.3K | 34.9K | +55% | +$567.4K |
| 2021-09-01 | 2021-08-31 | DHR | Danaher Corporation | Raskas Daniel | SVP - Corp. Development | G - Gift | $0.00 | -306 | 22.2K | -1% | $0 |
Purchase Sale Sale after option exercise All abbreviations